SABSW
SAB Biotherapeutics Inc. Warrant
$0.029+-0.000 (-0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.029
High
$0.029
Low
$0.029
Volume
0.00M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
SAB BIO Reports Full Year 2024 Operating and Financial Results
MIAMI, March 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), ("SAB BIO" or the "Company"), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.